Relmada Therapeutics Stock (RLMD)
Track Relmada Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
RLMD
Relmada Therapeutics
healthcare
$7.23
▲ +6.60 (+1000.00%) past year
Market Cap
$752.06M
P/E Ratio
—
1Y Return
+1000.00%
EPS (TTM)
-$1.11
Read the latest TheStreet Pro articles mentioning Relmada Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning RLMD yet.
Daily Diary Mentions
0 mentionsNo diary mentions for RLMD yet.